Article History
Received: 31 March 2019
Accepted: 13 November 2019
First Online: 29 November 2019
Ethics approval and consent to participate
: Ethics approval was gained from the Sydney Children’s Hospital Network (LNR/18/SCHN/24) and written informed consent was received from all participants.
: Consent was received from participants for the use of direct quotes in the paper.
: Dr. Holly Seale has previously received funding from drug companies for investigator driven research and consulting fees to present at conferences/workshops and develop resources (bio-CSL/Sequiris, GSK and Sanofi Pasteur). She has also participated in advisory board meeting for Sanofi Pasteur. Dr. Seale is an editorial board member for BMC Infectious Diseases. The other authors do not have anything to declare.